IRLAB Therapeutics Gestion
Gestion contrôle des critères 1/4
We currently do not have sufficient information about the CEO.
Informations clés
Kristina Torfgard
Directeur général
n/a
Rémunération totale
| Pourcentage du salaire du PDG | n/a |
| Durée du mandat du directeur général | less than a year |
| Propriété du PDG | n/a |
| Durée moyenne d'occupation des postes de direction | 11.8yrs |
| Durée moyenne du mandat des membres du conseil d'administration | 2.5yrs |
Mises à jour récentes de la gestion
Recent updates
Is IRLAB Therapeutics (STO:IRLAB A) Using Debt Sensibly?
Oct 30
IRLAB Therapeutics (STO:IRLAB A) Has Debt But No Earnings; Should You Worry?
Jun 06Here's Why We're Watching IRLAB Therapeutics' (STO:IRLAB A) Cash Burn Situation
Jan 04Here's Why IRLAB Therapeutics (STO:IRLAB A) Must Use Its Cash Wisely
Sep 21We Think IRLAB Therapeutics (STO:IRLAB A) Needs To Drive Business Growth Carefully
Mar 18IRLAB Therapeutics (STO:IRLAB A) Is In A Good Position To Deliver On Growth Plans
Dec 01We Like IRLAB Therapeutics' (STO:IRLAB A) Earnings For More Than Just Statutory Profit
May 19We're Interested To See How IRLAB Therapeutics (STO:IRLAB A) Uses Its Cash Hoard To Grow
Sep 11We're Interested To See How IRLAB Therapeutics (STO:IRLAB A) Uses Its Cash Hoard To Grow
Apr 30What Is The Ownership Structure Like For IRLAB Therapeutics AB (publ) (STO:IRLAB A)?
Mar 19We Think IRLAB Therapeutics (STO:IRLAB A) Can Afford To Drive Business Growth
Jan 25Our View On IRLAB Therapeutics' (STO:IRLAB A) CEO Pay
Dec 21What Is The Ownership Structure Like For IRLAB Therapeutics AB (publ) (STO:IRLAB A)?
Nov 25
PDG
Kristina Torfgard (61 yo)
less than a year
Titularisation
Dr. Kristina Torfgard, Ph.D. is Chief Executive Officer of IRLAB Therapeutics AB (publ) from August 1, 2024. Dr. Torfgard served as Vice President & Global Project Head at Albireo AB. Dr. Torfgard served a...
Équipe de direction
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| Chief Executive Officer | less than a year | pas de données | pas de données | |
| Chief Financial Officer | 7.8yrs | pas de données | 0.46% SEK 3.4m | |
| Chief Scientific Officer | 11.8yrs | pas de données | 1.46% SEK 10.7m | |
| Chief Information Officer and Director of Computational Chemistry & Biology | 11.8yrs | pas de données | 0.50% SEK 3.7m | |
| Global IR & Communications | no data | pas de données | pas de données | |
| Head of Finance & Human Resource and Director of Accounting & Human Resources | 11.8yrs | pas de données | 0.70% SEK 5.1m | |
| Executive VP and Head of R&D | no data | SEK 1.70m | 1.44% SEK 10.5m | |
| Chief Medical Officer | 11.8yrs | SEK 5.00k | 1.22% SEK 8.9m |
11.8yrs
Durée moyenne de l'emploi
62yo
Âge moyen
Gestion expérimentée: IRLAB A's management team is seasoned and experienced (11.8 years average tenure).
Membres du conseil d'administration
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| Independent Director | 8.8yrs | SEK 256.25k | 0.081% SEK 590.8k | |
| Independent Chairman of the Board | 6.8yrs | SEK 400.00k | 0.027% SEK 197.4k | |
| Director | 1.4yrs | SEK 147.50k | pas de données | |
| Independent Director | 1.4yrs | SEK 160.00k | pas de données | |
| Director | 7.8yrs | SEK 3.10m | 0.012% SEK 84.6k | |
| Independent Director | 2.5yrs | SEK 264.17k | 0.015% SEK 112.8k | |
| Director | 1.4yrs | SEK 175.00k | 8.71% SEK 63.7m |
2.5yrs
Durée moyenne de l'emploi
62yo
Âge moyen
Conseil d'administration expérimenté: IRLAB A's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.